company background image
0KW4 logo

ResMed LSE:0KW4 Stock Report

Last Price

US$237.74

Market Cap

US$34.8b

7D

-1.0%

1Y

37.3%

Updated

22 Dec, 2024

Data

Company Financials +

ResMed Inc.

LSE:0KW4 Stock Report

Market Cap: US$34.8b

0KW4 Stock Overview

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details

0KW4 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 32.1% below our estimate of its fair value

Earnings are forecast to grow 11.06% per year

Earnings have grown 16.8% per year over the past 5 years

Risk Analysis

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

ResMed Inc. Competitors

Smith & Nephew

LSE:SN.

UK£8.5b

NIOX Group

AIM:NIOX

UK£251.5m

ConvaTec Group

LSE:CTEC

UK£4.5b

EKF Diagnostics Holdings

AIM:EKF

UK£120.7m

Price History & Performance

Summary of share price highs, lows and changes for ResMed
Historical stock prices
Current Share PriceUS$237.74
52 Week HighUS$260.00
52 Week LowUS$164.88
Beta0.68
1 Month Change-2.12%
3 Month Change-3.15%
1 Year Change37.29%
3 Year Change-7.83%
5 Year Change52.70%
Change since IPO131.26%

Recent News & Updates

Recent updates

Shareholder Returns

0KW4GB Medical EquipmentGB Market
7D-1.0%-3.5%-2.6%
1Y37.3%-10.6%2.4%

Return vs Industry: 0KW4 exceeded the UK Medical Equipment industry which returned -10.6% over the past year.

Return vs Market: 0KW4 exceeded the UK Market which returned 2.4% over the past year.

Price Volatility

Is 0KW4's price volatile compared to industry and market?
0KW4 volatility
0KW4 Average Weekly Movement3.6%
Medical Equipment Industry Average Movement6.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0KW4 has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0KW4's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19899,980Mick Farrellwww.resmed.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

ResMed Inc. Fundamentals Summary

How do ResMed's earnings and revenue compare to its market cap?
0KW4 fundamental statistics
Market capUS$34.82b
Earnings (TTM)US$1.11b
Revenue (TTM)US$4.81b

31.3x

P/E Ratio

7.2x

P/S Ratio

Is 0KW4 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0KW4 income statement (TTM)
RevenueUS$4.81b
Cost of RevenueUS$2.00b
Gross ProfitUS$2.80b
Other ExpensesUS$1.69b
EarningsUS$1.11b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.58
Gross Margin58.33%
Net Profit Margin23.15%
Debt/Equity Ratio13.0%

How did 0KW4 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

26%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:45
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ResMed Inc. is covered by 56 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterANZ Equities Pty Limited
Russell WrightAPP Securities Pty Ltd.
David RescottBaird